newsfilter
← Latest News
Business Wire·

NeoGenomics to Highlight RaDaR ST MRD Assay at ESMO Congress 2025

NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, today announced the presentation of assay-relevant data, including interventional therapy trials in